Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

High frequency of HLA-B44 allelic losses in human solid tumors.

Human immunology - 1 Oct 2003

Cabrera Teresa, Maleno Isabel, Lopez-Nevot Miguel Angel, Redondo Maximino, Fernandez Maria Angustias, Collado Antonia, Garrido Federico

Abstract excerpt

Human leukocyte antigen (HLA) class I downregulation, a frequent phenomenon observed in a variety of human tumors, favors tumor immune escape from T-lymphocyte recognition. However, it is not known whether a particular HLA class I allele is lost more frequently than others. To address this question we analyzed HLA class I expression in tumor tissues derived from 300 patients diagnosed as having breast,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Carcinoma
Share to Histocompatibility Antigens Class I

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to HLA-B Antigens

Share to HLA-B44 Antigen

Share to Immunohistochemistry

Share to Loss of Heterozygosity

Share to Neoplasms

Source

Identifiers

PMID: 14522091
DOI: 10.1016/s0198-8859(03)00164-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

High frequency of HLA-B44 allelic losses in human solid tumors.PMID 14522091Read ↗

High frequency of altered HLA class I phenotypes in laryngeal carcinomas.Semantic proximity Read ↗

Low prevalence of selective human leukocyte antigen (HLA)-A and HLA-B epitope losses in early-passage tumor cell lines.Semantic proximity Read ↗

Human leukocyte antigen class I allelic and haplotype loss in squamous cell carcinoma of the head and neck: clinical and immunogenetic consequences.Semantic proximity Read ↗

High frequency of altered HLA class I phenotypes in invasive breast carcinomas.Semantic proximity Read ↗

Altered MHC class I antigens in tumors.Semantic proximity Read ↗

Analysis of HLA class I alterations in tumors: choosing a strategy based on known patterns of underlying molecular mechanisms.Semantic proximity Read ↗

The transition from HLA-I positive to HLA-I negative primary tumors: the road to escape from T-cell responses.Semantic proximity Read ↗

The Escape of Cancer from T Cell-Mediated Immune Surveillance: HLA Class I Loss and Tumor Tissue ArchitectureSemantic proximity Read ↗

In Situ Detection of Individual Classic MHC-I Gene Products in Cancer.Semantic proximity Read ↗

Human monoclonal antibodies as a tool for the detection of HLA class I allele-specific expression loss in head-and-neck squamous cell carcinoma and corresponding lymph node metastases.Semantic proximity Read ↗

Characterization of HLA class I altered phenotypes in a panel of human melanoma cell lines.Semantic proximity Read ↗

Different mechanisms can lead to the same altered HLA class I phenotype in tumors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.